You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 282 No. 20, November 24, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Statistics and Research Methods
 •Violence and Human Rights
 •Human Rights
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Keeping Research Subjects Out of Harm's Way

Gary B. Ellis, PhD

JAMA. 1999;282:1963-1965.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Observers of human experimentation in biomedicine and behavior are sounding cautionary notes that demand attention. In scientific research, "continued vigilance [is] critical to protecting human subjects," reports the US General Accounting Office.1 "The effectiveness of IRBs is in jeopardy," concludes an analysis of institutional review boards (IRBs) by the US Department of Health and Human Services' Office of Inspector General. "With this report, we offer a warning signal," says the inspector general.2 In this issue of THE JOURNAL, Woodward identifies trends that "erode" human subject protections.3 These are strong words that connote peril. Given that the inspector general also declares, "We do not document, nor do we suggest that widespread harm is being done to human subjects,"2 the words are, perhaps, too strong. It is, after all, by any probabilistic measure, relatively safe to be a human research subject. This is precisely the time to take . . . [Full Text of this Article]

Author Affiliation: Office for Protection from Research Risks, Office of the Director, National Institutes of Health, Bethesda, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Challenges to Human Subject Protections in US Medical Research
Beverly Woodward
JAMA. 1999;282(20):1947-1952.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risks and Wrongs in Social Science Research: An Evaluator's Guide to the IRB
Oakes
Eval Rev 2002;26:443-479.
ABSTRACT  

Ethical Oversight of Public Health Research: Can Rules and IRBs Make a Difference in Developing Countries?
London
AJPH 2002;92:1079-1084.
ABSTRACT | FULL TEXT  

Moving From Compliance to Conscience: Why We Can and Should Improve on the Ethics of Clinical Research
Kahn and Mastroianni
Arch Intern Med 2001;161:925-928.
FULL TEXT  

When is surgery research? Towards an operational definition of human research
Margo
J. Med. Ethics 2001;27:40-43.
ABSTRACT | FULL TEXT  

Human Tissue Research in the Genomic Era of Medicine: Balancing Individual and Societal Interests
Ashburn et al.
Arch Intern Med 2000;160:3377-3384.
ABSTRACT | FULL TEXT  

A new look at international research ethics
Benatar and Singer
BMJ 2000;321:824-826.
FULL TEXT  

Protection for Human Subjects in Medical Research
Kaufman et al.
JAMA 2000;283:2387-2390.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.